These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Systematic review of the prevalence of nodal metastases and the prognostic utility of sentinel lymph node biopsy in cutaneous squamous cell carcinoma. Tejera-Vaquerizo A; García-Doval I; Llombart B; Cañueto J; Martorell-Calatayud A; Descalzo-Gallego MA; Sanmartín O J Dermatol; 2018 Jul; 45(7):781-790. PubMed ID: 29701281 [TBL] [Abstract][Full Text] [Related]
8. Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study. Roscher I; Falk RS; Vos L; Clausen OPF; Helsing P; Gjersvik P; Robsahm TE JAMA Dermatol; 2018 Apr; 154(4):428-434. PubMed ID: 29516080 [TBL] [Abstract][Full Text] [Related]
9. Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system. Schmitt AR; Brewer JD; Bordeaux JS; Baum CL JAMA Dermatol; 2014 Jan; 150(1):19-24. PubMed ID: 24226651 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study. Levine DE; Karia PS; Schmults CD JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278 [TBL] [Abstract][Full Text] [Related]
11. The incidence and risk factors of metastasis for cutaneous squamous cell carcinoma--implications on the T-classification system. Brougham ND; Tan ST J Surg Oncol; 2014 Dec; 110(7):876-82. PubMed ID: 25088537 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. Jambusaria-Pahlajani A; Kanetsky PA; Karia PS; Hwang WT; Gelfand JM; Whalen FM; Elenitsas R; Xu X; Schmults CD JAMA Dermatol; 2013 Apr; 149(4):402-10. PubMed ID: 23325457 [TBL] [Abstract][Full Text] [Related]
13. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study. Tschetter AJ; Campoli MR; Zitelli JA; Brodland DG J Am Acad Dermatol; 2020 Jan; 82(1):139-148. PubMed ID: 31279037 [TBL] [Abstract][Full Text] [Related]
14. Cutaneous Squamous Cell Carcinoma: Updates in Staging and Management. Bander TS; Nehal KS; Lee EH Dermatol Clin; 2019 Jul; 37(3):241-251. PubMed ID: 31084718 [TBL] [Abstract][Full Text] [Related]
15. Risk factors and timing of subsequent cutaneous squamous cell carcinoma in patients with cutaneous squamous cell carcinoma: A retrospective cohort study. Rodriguez M; Beal BT; Manmohan M; Simmons E; Varra V; Xiong D; Eversman A; Briskin IN; Knackstedt T; Vidimos AT J Am Acad Dermatol; 2021 Mar; 84(3):719-724. PubMed ID: 32861709 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the American Joint Committee on Cancer Seventh Edition and Brigham and Women's Hospital Cutaneous Squamous Cell Carcinoma Tumor Staging in Immunosuppressed Patients. Gonzalez JL; Cunningham K; Silverman R; Madan E; Nguyen BM Dermatol Surg; 2017 Jun; 43(6):784-791. PubMed ID: 28079640 [TBL] [Abstract][Full Text] [Related]
17. Comparison of tumor staging systems for cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. Inda JJ; Kabat BF; Larson MC; Slager SL; Baum CL J Am Acad Dermatol; 2019 Mar; 80(3):639-645. PubMed ID: 30165169 [TBL] [Abstract][Full Text] [Related]
18. Impact of Gene Expression Profile Testing on the Management of Squamous Cell Carcinoma by Dermatologists. Rebeca T; Giselle P; Litchman GH; Rigel DS J Drugs Dermatol; 2019 Oct; 18(10):980-984. PubMed ID: 31584775 [TBL] [Abstract][Full Text] [Related]
19. Cutaneous squamous cell carcinoma staging may influence management in users: A survey study. Patel VA; McCullum C; Sparks AD; Schmults CD; Arron ST; Jambusaria-Pahlajani A Cancer Med; 2022 Jan; 11(1):94-103. PubMed ID: 34796670 [TBL] [Abstract][Full Text] [Related]
20. Stratification of Poor Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients Using the American Joint Committee on Cancer Eighth Edition and Brigham and Women's Hospital Staging Systems. Blechman AB; Carucci JA; Stevenson ML Dermatol Surg; 2019 Sep; 45(9):1117-1124. PubMed ID: 30640779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]